113 related articles for article (PubMed ID: 38295990)
1. Clinical relevance, mechanisms, and evolution of polymyxin B heteroresistance carbapenem-resistant Klebsiella pneumoniae: A genomic, retrospective cohort study.
Luo Q; Xu L; Wang Y; Fu H; Xiao T; Yu W; Zhou W; Zhang K; Shen J; Ji J; Ying C; Xiao Y
Clin Microbiol Infect; 2024 Apr; 30(4):507-514. PubMed ID: 38295990
[TBL] [Abstract][Full Text] [Related]
2. Insertion sequence mediating mrgB disruption is the major mechanism of polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from China.
Chen X; Li P; Sun Z; Xu X; Jiang J; Su J
J Glob Antimicrob Resist; 2022 Sep; 30():357-362. PubMed ID: 35817263
[TBL] [Abstract][Full Text] [Related]
3. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
Tian Y; Zhang Q; Wen L; Chen J
Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
[TBL] [Abstract][Full Text] [Related]
4. Carbapenem-Resistant
Band VI; Satola SW; Burd EM; Farley MM; Jacob JT; Weiss DS
mBio; 2018 Mar; 9(2):. PubMed ID: 29511071
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of carbapenem-resistant Klebsiella pneumoniae ST15 of producing KPC-2, SHV-106 and CTX-M-15 in Anhui, China.
Zhao H; He Z; Li Y; Sun B
BMC Microbiol; 2022 Nov; 22(1):262. PubMed ID: 36319965
[TBL] [Abstract][Full Text] [Related]
6. Resistance evolution of hypervirulent carbapenem-resistant
Jin X; Chen Q; Shen F; Jiang Y; Wu X; Hua X; Fu Y; Yu Y
Emerg Microbes Infect; 2021 Dec; 10(1):1129-1136. PubMed ID: 34074225
[TBL] [Abstract][Full Text] [Related]
7. Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
Cienfuegos-Gallet AV; Zhou Y; Ai W; Kreiswirth BN; Yu F; Chen L
Microbiol Spectr; 2022 Apr; 10(2):e0229021. PubMed ID: 35230130
[TBL] [Abstract][Full Text] [Related]
8. Role of the ISKpn element in mediating mgrB gene mutations in ST11 hypervirulent colistin-resistant
Zhu L; Li P; Zhang G; He Z; Tao X; Ji Y; Yang W; Zhu X; Luo W; Liao W; Chen C; Liu Y; Zhang W
Front Microbiol; 2023; 14():1277320. PubMed ID: 37840706
[TBL] [Abstract][Full Text] [Related]
9. Clinical, biological and genome-wide comparison of carbapenem-resistant Klebsiella pneumoniae with susceptibility transformation to polymyxin B during therapy.
Wang Y; Luo Q; Chen T; Chi X; Zhou Y; Fu H; Lu P; Xiong L; Xiao T; Zheng B; Shen P; Xiao Y
Clin Microbiol Infect; 2023 Oct; 29(10):1336.e1-1336.e8. PubMed ID: 37423426
[TBL] [Abstract][Full Text] [Related]
10. Molecular patterns of clinically important fluoroquinolone resistance in multidrug-resistant
Cai G; Wang Y
J Med Microbiol; 2022 Nov; 71(11):. PubMed ID: 36346828
[No Abstract] [Full Text] [Related]
11. Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital.
Zhang N; Qi L; Liu X; Jin M; Jin Y; Yang X; Chen J; Qin S; Liu F; Tang Y; Jia R; Zhang X; Wang Y; Guo J; Liu J; Wang C; Chen Y
Microbiol Spectr; 2022 Oct; 10(5):e0169022. PubMed ID: 36190403
[TBL] [Abstract][Full Text] [Related]
12. Ceftazidime/avibactam Improves the Antibacterial Efficacy of Polymyxin B Against Polymyxin B Heteroresistant KPC-2-Producing
Ma X; He Y; Yu X; Cai Y; Zeng J; Cai R; Lu Y; Chen L; Chen C; Huang B
Front Microbiol; 2019; 10():2029. PubMed ID: 31551966
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Study of Colistin Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae Strains in China.
Weng Y; Wang T; Huang B; Yu H; Jia W; Shan B; Qu F; Tang Y; Chen L; Du H
Microbiol Spectr; 2023 Aug; 11(4):e0221822. PubMed ID: 37428093
[TBL] [Abstract][Full Text] [Related]
14. Molecular and epidemiological surveillance of polymyxin-resistant Klebsiella pneumoniae strains isolated from Brazil with multiple mgrB gene mutations.
da Silva KE; Thi Nguyen TN; Boinett CJ; Baker S; Simionatto S
Int J Med Microbiol; 2020 Oct; 310(7):151448. PubMed ID: 33092694
[TBL] [Abstract][Full Text] [Related]
15. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study.
Olaitan AO; Diene SM; Kempf M; Berrazeg M; Bakour S; Gupta SK; Thongmalayvong B; Akkhavong K; Somphavong S; Paboriboune P; Chaisiri K; Komalamisra C; Adelowo OO; Fagade OE; Banjo OA; Oke AJ; Adler A; Assous MV; Morand S; Raoult D; Rolain JM
Int J Antimicrob Agents; 2014 Dec; 44(6):500-7. PubMed ID: 25264127
[TBL] [Abstract][Full Text] [Related]
16. Insertion sequences disrupting mgrB in carbapenem-resistant Klebsiella pneumoniae strains in Brazil.
Silva DMD; Faria-Junior C; Nery DR; Oliveira PM; Silva LOR; Alves EG; Lima GRCEC; Pereira AL
J Glob Antimicrob Resist; 2021 Mar; 24():53-57. PubMed ID: 33246210
[TBL] [Abstract][Full Text] [Related]
17. Recombination Drives Evolution of Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 11 KL47 to KL64 in China.
Chen T; Wang Y; Zhou Y; Zhou W; Chi X; Shen P; Zheng B; Xiao Y
Microbiol Spectr; 2023 Feb; 11(1):e0110722. PubMed ID: 36622219
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Epidemiology and Virulence Characteristics of Carbapenem-Resistant
Zhao Y; Zhang S; Fang R; Wu Q; Li J; Zhang Y; Rocker A; Cao J; Lithgow T; Zhou T
Infect Drug Resist; 2020; 13():931-940. PubMed ID: 32280249
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ST11 and ST15 Carbapenem-Resistant Hypervirulent
Song S; Zhao S; Wang W; Jiang F; Sun J; Ma P; Kang H
Infect Drug Resist; 2023; 16():6017-6028. PubMed ID: 37705511
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors and Molecular Mechanism of Polymyxin B Resistance in Carbapenem-Resistant
Xu X; Zhu R; Lian S; Zhang H; Chen X; Fan L; Chen P; Cao Y
Infect Drug Resist; 2022; 15():7485-7494. PubMed ID: 36544993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
